New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
09:46 EDTCMCSA, TWC, CHTR'Nothing' points to Comcast joining Charter for TWC bid, CNBC reports
"Nothing" is pointing to Comcast (CMCSA) joining Charter (CHTR) to bid for Time Warner Cable (TWC), CNBC's David Faber reports.
News For CMCSA;CHTR;TWC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 23, 2015
05:37 EDTTWCTime Warner Cable upgraded to Buy from Hold at Jefferies
Subscribe for More Information
April 22, 2015
06:39 EDTTWC, CMCSARegulators evaluating Comcast's track record, NY Times says
Subscribe for More Information
06:25 EDTCMCSA, TWCFCC staff to meet with commissioners today on Comcast deal, Reuters reports
FCC staff is slated to brief the agency's commissioners later today on their review of Comcast's (CMCSA) proposed merger with Time Warner Cable (TWC), according to Reuters, which cited two unnamed sources. The staff is also slated to discuss its view of a $48B pending deal between AT&T (T) and DirecTV (DTV), the news agency quoted one of the sources as saying. Reference Link
06:23 EDTCMCSA, TWCTime Warner Cable volatility up on uncertainty of completion of Comcast deal
Subscribe for More Information
April 21, 2015
18:53 EDTCMCSAFox, NBC say Verizon cable packages violate license terms, Washington Post says
Subscribe for More Information
15:04 EDTCMCSA, TWCHesse as reviewer may be Comcast 'worst-case scenario,' CT Financial says
Cleveland State University Law professor Christopher Sagers said that in some ways having Renata Hesse oversee the DOJ's review of the proposed merger of Comcast (CMCSA) and Time Warner Cable (TWC) could be a “worst-case scenario” for the companies, citing her experience and reputation. If Comcast is seen as merging to thwart Time Warner Cable from launching an over-the-top streaming service, then "that’s virtually a horizontal merger" which would be a "very serious theory of harm," according to the professor. Reference Link
13:36 EDTTWC, CMCSASenators urge rejection of potential Comcast, Time Warner merger, Reuters says
Subscribe for More Information
April 20, 2015
17:04 EDTCHTROn The Fly: Top stock stories for Monday
Stocks on Wall Street were higher for the day, beginning the session sharply higher and remaining in positive territory throughout. China’s central bank announced a reduction in bank reserve requirements in an effort to increase liquidity and spur economic growth within the country. Following the open, the market moved in a relatively narrow range as investors await the latest round of earnings reports for one of the season's heavier weeks. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index came in at 0.42 versus expectations for positive 0.1. In Asia, the People's Bank of China lowered its reserve requirement ratio, by 1 percentage point, the lowest since the financial crisis. Despite this, the Shanghai Composite Index fell 1.6% because regulators had already begun curbing speculative trading on Friday. COMPANY NEWS: Morgan Stanley (MS) advanced 0.57%, or 21c, to $36.96 after reporting earnings prior to the market open. The bank beat on both EPS and revenue, and also raised its dividend to 15c from 10c. CEO James Gorman was pleased with the quarter and cited growth across the majority of the company's operations. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which rose 12.55% to end the session at $74.16 after reporting EPS and revenue in excess of analyst expectations. During its earnings conference call, the company appeared confident on its 2015 offerings which include Disney (DIS) Princess and Frozen product lines. Also higher was Rovi (ROVI), gaining 8.64% to close the day at $19.11 after renewing its licensing and program guide agreement with Charter (CHTR). Among the noteworthy losers was Caesars Entertainment (CZR), tumbling 17.01% to $10 after failing to reach an agreement on its restructuring. Also lower were a number of medical companies involved in the development of CAR-T cancer therapies, including Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP). The drop followed disappointing, small-scale studies presented during the annual meeting of the American Association for Cancer Research. INDEXES: The Dow rose 208.63, or 1.17%, to 18,034.93, the Nasdaq advanced 62.79, or 1.27%, to 4,994.6, and the S&P 500 gained 19.22, or 0.92%, to 2,100.4.
12:31 EDTCHTROn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after China’s central bank relaxed reserve requirements for its banks. The nation's own stock market struggled to overcome the cross current of other actions taken to cut down on speculative trading there, but U.S. stock markets surged at the open and had not looked back by midday. The domestic economic calendar has quiet and earnings continue to be the focal point at home, as a great number of S&P 500 companies prepare to report this week. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index had a reading of -0.42, versus expectations for a +0.10 reading. A reading below zero represents economic activity below trend. In China, the People's Bank of China cut the reserve-requirement ratio, or the amount of reserves lenders need to hold, by 1 full percentage point, which was the biggest cut since the depths of the financial crisis and more than expected by economists. However, the Shanghai Composite Index still dropped 1.6%, since the reserve-requirement cut came after regulators had moved to curb speculative trading with actions taken Friday. COMPANY NEWS: Shares of Morgan Stanley (MS) advanced 1% after the bank's headline earnings excluding certain adjustments and tax benefits beat expectations. CEO James Gorman noted that the first quarter of the year was the bank's "strongest quarter in many years with improved performance across most areas of the firm." Morgan Stanley also increased its quarterly dividend to 15c per share from 10c per share. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which gained 10% after the toymaker's sales and profits widely topped expectations in its fiscal first quarter. Also higher was Rovi (ROVI), which gained more than 10% after the company announced it has renewed its patent license and interactive program guide product agreement with Charter Communications (CHTR). Among the noteworthy losers was FARO Technologies (FARO), which dropped 25% and was downgraded by Noble Financial and Needham after the preannounced lower than expected first quarter revenue. Also lower were a number of companies that are developing CAR-T cancer therapies following the annual meeting of the American Association for Cancer Research. Mizuho analyst Peter Lawson attributed the pullback to disappointment in this weekend's solid tumor data on a small number of patients with advanced cancers who were given CAR-T therapy developed by Novartis (NVS) and the University of Pennsylvania. Shares of Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP) were all lower near noon. INDEXES: Near midday, the Dow was up 236.19, or 1.32%, to 18,062.49, the Nasdaq was up 59.54, or 1.21%, to 4,991.35, and the S&P 500 was up 21.82, or 1.05%, to 2,103.00.
12:08 EDTCHTRTiming of Rovi renewal with Charter a plus, says JPMorgan
JPMorgan said the timing of the closing of Rovi's (ROVI) renewal of its IP and programming guide agreement with Charter (CHTR) is advantageous given Rovi's other impending renewals and should give some confidence that large service provider renewals don't hinge on the outcome of the company's court case with Netflix (NFLX). However, the firm added that it would not be surprised to see more volatility in Rovi shares if court rulings favor Netflix and it kept a Neutral rating on the stock.
11:10 EDTTWCStocks with call strike movement; TWC YAHOO
Subscribe for More Information
10:29 EDTTWCOptions with increasing implied volatility: PNK PSEC TWC
Subscribe for More Information
09:52 EDTTWC, CHTR, CMCSARovi deal with Charter a 'material' positive, says Piper Jaffray
Subscribe for More Information
08:01 EDTCHTRRovi, Charter sign multi-year license renewal
Rovi (ROVI) announced that the company has renewed its patent license and interactive program guide product agreement with Charter Communications (CHTR). The license renewal extends Charter’s IPG patent license. Under the terms of the agreement, Charter will also be able to license Rovi’s products and services, including Rovi Search, Recommendations and Conversation Services, Rovi Metadata and Rovi Analytics.
07:56 EDTCMCSA, CHTR, TWCCharter would pursue Time Warner if Comcast deal blocked, says UBS
Subscribe for More Information
06:39 EDTTWC, CMCSADOJ lawyers leaning towards recommending block of Comcast deal, NY Times says
The Justice Department's staff lawyers are leaning towards recommending that Comcast's (CMCSA) takeover of Time Warner Cable (TWC) be blocked, according to The New York Times, which cited an unnamed source. Reference Link
05:55 EDTCMCSAStocks with implied volatility movement; RSX CMCSA
Stocks with implied volatility movement; Market Vectors Russia ETF (RSX) 40, Comcast (CMCSA) 25 according to iVolatility.
05:47 EDTTWCStocks with implied volatility movement; TWC CSX
Subscribe for More Information
April 19, 2015
15:24 EDTCMCSAComcast's 'Furious 7' leads U.S. weekend box office with $29.1M
For the weekend of April 19, Universal's (CMCSA, CMCSK) "Furious 7" topped domestic box office charts at $29.1M. Sony's (SNE) "Paul Blart: Mall Cop 2" landed in second place with $24M for the weekend while Universal's "Unfriended" came in third with $16M. Fox's (FOX, FOXA) "Home" and "The Longest Ride" took fourth and fifth place at $10.3M and $6.8M, respectively. Data gathered by Rentrak.
12:23 EDTCMCSA, TWCTime Warner Cable, Comcast set to meet with DoJ, WSJ says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use